Immunophotonics, Inc. — Form D
Immunophotonics, Inc. of St. Louis, MO, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-15. The offering totals $4.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-03-15
- Form: D
- Accession: 0001490953-24-000001
- Industry: Pharmaceuticals
- Exemptions: 04, 06b
- Total offering: $4.0M
- Amount sold: $1.5M
- Remaining: $2.5M
- Minimum investment: $25K
- Investors: 17
- Date of first sale: 2024-02-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-507751
Issuer
- Name: Immunophotonics, Inc.
- CIK: 0001490953
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 4340 Duncan Ave., St. Louis, MO, 63110
- Phone: 314-501-1919
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Luciano Alleruzzo | Director | St. Louis, MO |
| Charlie R Bolten | Director | St. Louis, MO |
| Wei R Chen | Director | St. Louis, MO |
| Tomas Hode | Director | St. Louis, MO |
| Jonathan R Knowles | Director | St. Louis, MO |
| Bobby W Sandage | Director | St. Louis, MO |
| Miguel R Zubizarreta | Director | St. Louis, MO |
| Luciano Alleruzzo | Executive Officer | St. Louis, MO |
| Tomas Hode | Executive Officer | St. Louis, MO |
| Luciano Alleruzzo | Promoter | St. Louis, MO |
| Wei R Chen | Promoter | St. Louis, MO |
| Tomas Hode | Promoter | St. Louis, MO |
| David R Smoller | Director | West Henrietta, NY |
| Charlie E Bolten | Director | St. Louis, MO |
| Bobby E Sandage | Director | St. Louis, MO |
| Robert E Nordquist | Director | St. Louis, MO |
| Lu Alleruzzo | Executive Officer | St. Louis, MO |
| Peter A Jenkins | Director | St. Louis, MO |
| Peter A Jenkins | Executive Officer | St. Louis, MO |
| Shelly L Bishop | Director | Columbia, MO |
Other filings by this issuer (4)
More